The link between DVT and cancer is well established and stems from the complex interplay between tumor-related factors (TF, VEGF, IL-6, TNF-α), patient factors (hypercoagulability, immobilization, comorbidities), and treatment-related risks (surgery, chemotherapy, hormonal therapy, central venous catheters). The gene discussed is IL6; the disease is neoplasm.